Azobenzenes
Medchemexpress LLC Cp-409092 hydrochloride | 225240-86-8 | 99.8% | 333.81 g/mol | C17H20ClN3O2 | 10 MG
CP-409092 hydrochloride is a research-use small molecule described as a partial agonist of GABAA receptors with reported anti-anxiety activity. It is supplied as a solid for laboratory research and is not intended for human therapeutic use.
- Partial agonist of GABAA receptor, with anti-anxiety activity.
- High purity: 99.8% (reported).
- Solid, white to off-white appearance for handling and formulation.
- Recommended storage: 4°C sealed; in solvent, -80°C (up to 6 months) or -20°C (up to 1 month).
- Available in small research pack sizes; common pack: 10 MG.
- For research use only; not for clinical or human use.
eMolecules 2049872-86-6 | Medchem Express | GSK962 | 5mg | 489862907 | HY-103028 | 230.311 | C14H18N2O
Ambeed | 5-Amino-246-triiodoisophthaloyl dichloride | 1g | 601097172 | A330595 | 37441-29-5 | MFCD00270836 | 595.720 | C8H2Cl2I3NO2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
eMolecules 544678-85-5 | Medchem Express | DB04760 | 1mg | 536984011 | HY-125166 | MFCD09878513 | 410.425 | C22H20F2N4O2
Medchem Express | DB04760 | 1mg | 536984011 | HY-125166 | 544678-85-5 | MFCD09878513 | 410.425 | C22H20F2N4O2
![Medchemexpress LLC 4H,8H-Benzo[1,2-b:3,4-b']dipyran-4-one, 9,10-dihydro-3,5-dihydroxy-2-(4-methoxyphenyl)-8,8-dimethyl | 38226-86-7 | 368.38 | 5 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000416426.png-250.jpg)
Medchemexpress LLC 4H,8H-Benzo[1,2-b:3,4-b']dipyran-4-one, 9,10-dihydro-3,5-dihydroxy-2-(4-methoxyphenyl)-8,8-dimethyl | 38226-86-7 | 368.38 | 5 MG
β-Anhydroicaritin is isolated from Boswellia carterii Birdware and possesses important biological and pharmacological effects. It ameliorates the degradation of periodontal tissue, inhibits the synthesis and secretion of TNF-α and MMP-3 in diabetic rats, and decreases the overproduction of NO, IL-10, TNF-α, MCP-1, and IL-6 in peritonitis mice. Additionally, it inhibits the elevation of intracellular Ca2+ and markedly decreases iNOS protein expression.
- Antiosteoporosis properties
- Estrogen regulation properties
- Antitumor properties
- Ameliorates the degradation of periodontal tissue
- Inhibits the synthesis and secretion of TNF-α and MMP-3 in diabetic rats
- Decreases the overproduction of NO, IL-10, TNF-α, MCP-1, and IL-6 in peritonitis mice
- Inhibits the elevation of intracellular Ca2+
- Markedly decreases iNOS protein expression
Medchemexpress LLC Oxypeucedanin hydrate | 2643-85-8 | 5 MG
Oxypeucedanin hydrate is a natural product isolated from D. anethifolia. It exhibits mild toxicity on fibroblasts and parental lymphoma cells. This product is for research use only.
- Isolated from D. anethifolia
- Exhibits mild toxicity on fibroblasts and parental lymphoma cells
- Molecular weight of 304.29
- Chemical formula is C16H16O6
- Appears as an off-white to light yellow solid
- Purity of 98.0%
- Soluble in DMSO at 100 mg/mL
![Medchemexpress LLC Urea, N-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N' | 1166393-85-6 | 98.6% | 445.52 | 50 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000387730-logo.png-250.jpg){kind=logo}
Medchemexpress LLC Urea, N-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N' | 1166393-85-6 | 98.6% | 445.52 | 50 MG
PF-4618433 is a potent and selective PYK2 inhibitor, with an IC50 of 637 nM. It may be suitable for the research of osteoporosis, craniofacial and appendicular skeletal defects, and for targeted bone regeneration.
- Potent and selective PYK2 inhibitor with an IC50 of 637 nM.
- Promotes osteogenesis of hMSC cultures, increasing alkaline phosphatase (ALP) activity and mineralization.
- Enhances osteoblast proliferation.
- Enhances calcium deposition.
- Increases cell proliferation activity in murine bone marrow-derived mesenchymal stem cells (BMSC).
eMolecules 4254-85-7 | 1,5-DIHYDROXYPENTAN-3-ONE | AstaTech | MFCD06658431 | 118.132 | C5H10O3 | 95.000 | OCCC(=O)CCO | 0.25g | 297085484
1,5-DIHYDROXYPENTAN-3-ONE | AstaTech | 4254-85-7 | MFCD06658431 | 118.132 | C5H10O3 | 95.000 | OCCC(=O)CCO | 0.25g | 297085484
eMolecules 1215183-85-9 | ChemScene | 36-Dibromopicolinaldehyde | 100mg | 714110566 | CS-0146972 | MFCD16250664 | 264.904 | C6H3Br2NO
ChemScene | 2-Propylbenzene-13-diol | 250mg | 572195786 | CS-0128889 | 13331-19-6 | MFCD00100568 | 152.193 | C9H12O2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
![Medchemexpress LLC 4-N,6-N-bis[(4-fluoro-3-methylphenyl)methyl]pyrimidine-4,6-dicarboxamide | 544678-85-5 | MFCD09878513 | 99.2% | 410.42 g/mol | C22H20F2N4O2 | 1MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000238385.png-250.jpg)
Medchemexpress LLC 4-N,6-N-bis[(4-fluoro-3-methylphenyl)methyl]pyrimidine-4,6-dicarboxamide | 544678-85-5 | MFCD09878513 | 99.2% | 410.42 g/mol | C22H20F2N4O2 | 1MG
DB04760 is a potent, highly selective, non-zinc-chelating inhibitor of matrix metalloproteinase-13 (MMP-13) with a reported biochemical IC50 of 8 nM. Preclinical studies show the compound reduces paclitaxel-induced neurotoxicity and exhibits anticancer activity. The material is supplied as a light yellow to yellow solid with high purity and recommended storage conditions for powder and solution forms.
Medchemexpress LLC FzM1.8 | 322.3 g/mol | C18H14N2O4 | 10MG
FzM1 8 derives from FzM1 is an allosteric agonist of FZD4 with pEC50 of 6 4 FzM1 8 binds to FZD4 and activates the WNT/ -catenin pathway by promoting TCF/LEF transcriptional activity in the absence of any WNT ligand FzM1 8 stabilizes FZD4 with an increased affinity for heterotrimeric G protein and stimulates the release of the G subunit that in turn activates PI3K[1]
Medchemexpress LLC Beta-anhydroicaritin | 38226-86-7 | 99.7% | 368.38 g/mol | C21H20O6 | 10 MG
β-Anhydroicaritin is a prenylflavonoid natural product provided for laboratory research use. It is reported to exhibit biological activities such as anti-osteoporosis, estrogenic modulation, and anti-tumor effects, and is supplied as a small-scale research reagent suitable for biochemical and cellular studies.
- Prenylflavonoid natural product.
- Reported activities include anti-osteoporosis, estrogenic modulation, and anti-tumor effects.
- CAS number 38226-86-7 and molecular formula C21H20O6.
- High purity (99.7%).
- Available as a 10 mg research vial for biochemical assays.
Medchemexpress LLC Cdc7-IN-5 (compound I-B) | 1402057-86-6 | 96.7% | C25H23N3O5 | 10MG
Cdc7-IN-5 is a small-molecule inhibitor of the CDC7 serine-threonine kinase used in research on DNA replication and cell cycle regulation. The compound is provided as a dry solid with molecular formula C25H23N3O5, molecular weight 445.47, and reported purity around 96.7%.
- Inhibits CDC7 kinase activity in biochemical and cellular assays.
- Useful for studies of DNA replication and cell cycle control.
- Supplied as a dry solid with high reported purity for research use.
- Soluble in DMSO for preparation of concentrated stock solutions.
- Available in research-scale quantities, including 10 mg and sample sizes.
Medchemexpress LLC WR99210 50mg | 47326-86-3 | 394.7 g/mol | C14H18Cl3N5O2 | 50 MG
WR99210 is a potent dihydrofolate reductase (DHFR) inhibitor used in antiparasitic research and as a selection reagent for Plasmodium transfection. It is supplied as a research-grade free base and is used in laboratory studies that require selective inhibition of parasite DHFR.
- Potent dihydrofolate reductase (DHFR) inhibition with subnanomolar activity.
- Commonly used as a selection reagent for Plasmodium transfection experiments.
- Provided as the free base form suitable for research applications.
- Typical pack size: 50 mg.
- For research use only; not for human or clinical use.
Medchemexpress LLC PF-4618433 | 1166393-85-6 | 98.62% | 445.52 | 100 MG
PF-4618433 is a potent and selective PYK2 inhibitor, with an IC50 of 637 nM. It may be suitable for the research of osteoporosis, craniofacial and appendicular skeletal defects, and for targeted bone regeneration.
- Potent and selective PYK2 inhibitor.
- IC50 of 637 nM against PYK2.
- Promotes osteogenesis of hMSC cultures.
- Increases alkaline phosphatase (ALP) activity and mineralization.
- Enhances osteoblast proliferation.
- Enhances calcium deposition.
- Molecular weight: 445.52.
- Formula: C24H27N7O2.
- Appearance: Solid, white to off-white.
- Storage: Powder at -20°C for 3 years, 4°C for 2 years; in solvent at -80°C for 6 months, -20°C for 1 month.
- Purity: 98.62%.